Armstrong may admit to doping: report

Newspaper report says Armstrong said so to associates in a bid to restore his credibility

Image
AFPPTI New York
Last Updated : Jan 29 2013 | 2:34 PM IST
I / New York January 05, 2013, 11:41 IST

Disgraced cyclist Lance Armstrong, who was stripped of his seven Tour de France titles for doping, is weighing whether to admit he used performance-enhancing drugs, The New York Times reported.

Armstrong has told associates and anti-doping officials he is considering admitting publicly that he used blood transfusions and banned drugs during his cycling career in an effort to restore his credibility so he can become a competitive athlete again, the newspaper reported.

The Times did not name its sources but cited "several people with direct knowledge of the situation."

The International Cycling Union (UCI) late last year effectively erased Armstrong from the cycling history books when it decided not to appeal sanctions imposed on the American by the United States Anti-Doping Agency (USADA).

A damning report by USADA concluded that Armstrong helped orchestrate the most sophisticated doping program in the history of sport. The report included hundreds of pages of eyewitness testimony, emails, financial records and laboratory analysis of blood samples.

Armstrong has vehemently denied ever having doped.

Tim Herman, a lawyer for Armstrong, told the Times he was not aware of any admission plans.

"I do not know about that. I suppose anything is possible, for sure. Right now, that's really not on the table," Herman was quoted as saying.

*Subscribe to Business Standard digital and get complimentary access to The New York Times

Smart Quarterly

₹900

3 Months

₹300/Month

SAVE 25%

Smart Essential

₹2,700

1 Year

₹225/Month

SAVE 46%
*Complimentary New York Times access for the 2nd year will be given after 12 months

Super Saver

₹3,900

2 Years

₹162/Month

Subscribe

Renews automatically, cancel anytime

Here’s what’s included in our digital subscription plans

Exclusive premium stories online

  • Over 30 premium stories daily, handpicked by our editors

Complimentary Access to The New York Times

  • News, Games, Cooking, Audio, Wirecutter & The Athletic

Business Standard Epaper

  • Digital replica of our daily newspaper — with options to read, save, and share

Curated Newsletters

  • Insights on markets, finance, politics, tech, and more delivered to your inbox

Market Analysis & Investment Insights

  • In-depth market analysis & insights with access to The Smart Investor

Archives

  • Repository of articles and publications dating back to 1997

Ad-free Reading

  • Uninterrupted reading experience with no advertisements

Seamless Access Across All Devices

  • Access Business Standard across devices — mobile, tablet, or PC, via web or app

More From This Section

First Published: Jan 05 2013 | 11:41 AM IST

Next Story